Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Lannett Co/ Inc/
Recent news which mentions Lannett Co/ Inc/
Lannett bankruptcy; CVS turns away from acquisitions: The National Observer May 4, 2023
May 04, 2023
Tags
CVS Health
Redfin Corp/
National
From
Business Journals
Lab notes: Adaptimmune to reduce workforce; NRx completes $11M debt financing
November 11, 2022
Tickers
INNO
Tags
GlaxoSmithKline PLC
Incyte Corp/
Pharmaceuticals
From
Business Journals
Lab Notes: Tela Bio secures $50M loan deal; Senzo's home Covid-19 test achieves 100% accuracy
June 03, 2022
Tickers
INNO
Tags
Health Care
Lannett Co Inc
Antony Koblish
From
Business Journals
Lab Notes: Gene therapy milestone celebrated; CHOP pioneer Dr. Katherine High honored
May 13, 2022
Tickers
INNO
Tags
Emily Whitehead
David Porter
Stephan Grupp
From
Business Journals
Lab Notes: Jazz agrees to multimillion-dollar drug sale; Lannett takes 'major step' with biosimilar
April 01, 2022
Tickers
INNO
Tags
Jazz Pharmaceuticals plc (Ireland)
Inno
Lannett Co Inc
From
Business Journals
Lab Notes: Chimeron's Covid-19 vaccine candidate shows promise; Lannett gets 2nd NYSE delisting notice
March 25, 2022
Tickers
INNO
Tags
Insurance
Jolly Mazumdar
Biotech
From
Business Journals
Lab Notes: LIMR awarded research grant; Virpax posts positive study results for pain treatment
January 21, 2022
Tickers
INNO
Tags
A/ Brian Davis
Lannett Co/ Inc/
Virpax Pharmaceuticals Inc/
From
Business Journals
Lab Notes: Lannett files FDA application for new drug; Virpax to start clinical trial for knee pain drug candidate
December 23, 2021
Tickers
INNO
Tags
Lannett Co/ Inc/
Tim Crew
Vallon Pharmaceuticals Inc/
From
Business Journals
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.